PATENT CLAIM ANALYSIS

Application Number: 15893396
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "455000"]

Abstract:
The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.

Claim (Index 26):
The formulation of  claim 2  wherein the dispersant comprises gelatin, casein, lecithin, gum acacia, cholesterol, tragacanth, stearic acid, benzalkonium chloride, calcium stearate, glyceryl monostearate, cetostearyl alcohol, cetomacrogol emulsifying wax, sorbitan esters, polyoxyethylene alkyl ethers, polyoxyethylene caster oil derivatives, polyoxyethylene sorbitan fatty acid esters, polyethyleneglycols, methacrylic acid: methacrylate copolymers, aminoalkyl methacrylate copolymers, polyoxyethylene stearates, colloidol silicon dioxide, phosphates, sodium dodecyl sulfate, carboxy methylcellulose calcium, carboxymethylcellulose sodium, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethycellulose phthalate, noncrystalline cellulose, magnesium aluminum silicate, triethanolamine, polyvinyl alcohol, or polyvinylpyrrolidone or combinations thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14211659', '11846896', '13052798', '13719640', '13657135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589475035455592
- 35 USC 102 Novelty (BERT): 0.5041887592254718
- Combined Prediction Score: 0.7334716291135503
- Mean Citation Score: 263.475926
- Max Citation Score: 274.77957000000004
- Similarity Product: 211.982330584994

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test